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Supramolecular Functional Assemblies: Dynamic Membrane 





 Juan R. Granja*
a
 and Javier Montenegro*
a 
The fabrication of functional molecular devices constitutes one of the most important current challenges for chemical 
sciences. The complex processes accomplished by living systems continuously demand the assistance of non-covalent 
interactions between molecular building blocks. Additionally, these building blocks (proteins, membranes, nucleotides) are 
also constituted by self-assembled structures. Therefore, supramolecular chemistry is the discipline required to 
understand the properties of the minimal self-assembled building blocks of living systems and to develop new functional 
smart materials. In the first part of this feature article, we highlight selected examples of the preparation of 
supramolecular membrane transporters with special emphasis in the application of dynamic covalent bonds. In the second 
section of the paper we review recent breakthroughs in the preparation of peptide nanotubes hybrids with functional 
applications. The development of these devices constitutes an exciting process from where we can learn how to 
understand and manipulate supramolecular functional assemblies. 
 
1. Introduction 
A great number of different macromolecular architectures 
have been described since the emergence of supramolecular 
chemistry.
1-7
 Chemists have realized about the potential 
application of some of these particular molecular 
constructions and they have designed and tested a variety of 
functional supramolecular systems.
4,5,8-10
 In total synthesis, the 
requirements of a particular transformation trigger the 
development of new methodologies for new bond-forming 
reactions. Analogously, in supramolecular functional 
assemblies, the performance in a specific task is the driving 
force that dictates the design and methodological principles of 
the corresponding device. In other words, the function governs 
the supramolecular structure. Therefore, after the 
identification of a functional challenge, the supramolecular 
researcher envisions strategies to combine building blocks and 
weak interactions in order to modulate the shape and the 
properties of the final assembly. The functions that have been 
so far accomplished by supramolecular architectures are 
extensive and include applications in cellular delivery, 
molecular encapsulation and controlled release, energy 
conversion and storage, tissue regeneration, confined 
catalysis, self-healing materials and more.
4,5,10,11
 The 
development of supramolecular and dynamic chemistry has 
triggered new opportunities for the preparation of functional 
devices.
9,12
 The application of non-covalent interactions and 
dynamic bonds offers two critical advantages. On one hand it 
is the synthetic reward, as the target molecules are easily 
prepared by simple mixing appropriate counterparts such as 
hydrogen bond donors with acceptors or nucleophilic 
hydrazides with electrophilic aldehydes. On the other hand we 
have the reversibility of the ensembles, which represents an 
unmistakable advantage when preparing stimuli responsive 
functional materials. However, the comprehensive assessment 
of this myriad of functional macromolecular devices is far 
beyond the objective of this paper. Instead, in the first part of 
this feature article we will highlight a few selected examples of 
the design and synthesis of supramolecular membrane 
transporters with special attention in the implementation of 
dynamic covalent bonds. In the second section of the paper we 
will focus in the preparation of peptide nanotubular-shaped 
supramolecular polymers based on peptide hybrids, a simple 
tubular architecture with nanometric dimensions and a great 
potential for functional applications. Our group identifies these 
two important advantages (the synthetic and the 
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responsiveness) as key features of working molecular devices. 
The implementation of dynamic bonds as part of functional 
supramolecular assemblies increases the molecular diversity 
and minimizes the synthetic efforts that are required to 
achieve the optimal functional architecture. Furthermore, the 
dynamic processes involved in membrane transport and 
delivery, make dynamic bonds particularly interesting for the 
design and preparation of novel materials for cellular 
internalization and drug delivery.
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2. Membrane Transporters 
2.1. Dynamic covalent bonds for “Differential Sensing”. The human 
olfactory reception operates through pattern recognition. Humans 
can detect thousands of different odours with only around three 
hundred olfactory receptors. This system is incompatible with a 1 to 
1 recognition process. Therefore, a particular odorant substance 
activates a certain number of olfactory receptors with different 
intensity. This cross-responsive activation of olfactory receptors 
generates a pattern that is recognized as a unique fingerprint by the 
brain.
13
 This fascinating natural mechanism has inspired chemists to 




The amplification of the differences between similar molecules 
during membrane transport events has recently triggered new 
opportunities for differential sensing of small molecules
19
 as well as 
high molecular weight biopolymers (Fig. 1).
20
 This research program 
evolved from exciting results about conceptually new sensing 
assays based on fluorogenic vesicles developed in the group of Prof. 
Matile.
21-23
 In lipid bilayer differential sensing, short hydrophobic 
volatile aldehydes (odorants) were covalently captured with a 
cationic reactive dendron head (Fig. 1). The resulting amphiphilic 
dendron activated the transport, across lipid membranes, of a 
anionic polymer (e.g. calf thymus DNA).
19
 The fluorescence 
response obtained in the transport experiments, in large 
unilamellar vesicles (LUVs), was quantified and tabulated for each 
particular odorant in combination with several cationic heads (Fig. 
1). This data was subjected to statistical analysis that confirmed the 
viability of the method to distinguish aldehydes with a single carbon 
atom difference, cis/trans isomers and even enantiomers.
19
 The 
approach was tested for complex mixtures of odorants allowing the 
high-throughput differentiation of commercially available 
perfumes. This methodology was extended by charge inversion to 
create polyarginine artificial noses,
23
 by the development of 
alkoxamine and disulfide reactive counterions
24-26
 and by the 




Following on this concept, we have recently adapted this 
technology to the challenging differentiation of polymers with 
biological relevance (Fig. 1).
20
 In this case, we prepared small 
cationic peptides containing alkoxamine reactive residues. 
Conjugation with a variety of aldehydes provided cationic 
amphiphiles that performed as strong activators of the membrane 
translocation of different types of DNA molecules. Vesicle transport 
experiments of these cationic peptides with a collection of DNAs 
afforded the corresponding unique transport fingerprint for each of 
the DNA tested. Statistical analysis of this data allowed the DNA 
differentiation by pattern recognition with an impressive single 




2.2. Dynamic covalent amphiphiles for cellular internalization and 
delivery. The potential of dynamic covalent bonds for 
membrane transport and delivery purposes has triggered the 
attention of the chemistry community.
28
 One of the first 
examples, by Jean-Marie Lehn, explored the hydrazone bond 
formation between a guanidinium (cationic hydrophilic) 
reactive hydrazyde and a cholestenone (hydrophobic) 
electrophile. The resulting amphiphile was employed as an 
efficient vehicle for the transfection of luciferase-expressing 




Fig. 1. Differential Sensing in Lipid Bilayer Membranes (from left to right): Reactive dendrons (or peptides) react with hydrophobic aldehydes to afford cationic amphiphiles. The 
amphiphilic dendron hydrazones (or peptide oximes) are transferred to transport experiments in fluorogenic vesicles.
19,20
 The fluorescent transport data is tabulated and 
recognized as a unique fingerprint. In the case of hydrazone dendrons, the DNA is fixed (calf-thymus) and the aldehyde tails (odorants) are changed allowing the differentiation of 
odorants (fragrant sensing). In the case of the oxime peptides, the amphiphilic peptides are fixed and different nucleotides are employed in the vesicle transport experiments 
allowing nucleotide differentiation (DNA sensing). 
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The synthetic methodology developed for differential sensing 
in model membranes was also translated to the transport of 
functional DNA across the membrane of living cells (Fig. 
2B).
29,30
 The hydrazone connection between a collection of 
cationic hydrazides with different hydrophobic aldehyde tails 
allowed the preparation and screening of discrete libraries of 
dendronized amphiphiles for the transfection of siRNA into 
human cells.
29
 The protocol allowed the identification of 
single-component formulations that performed as efficient 
vehicles for siRNA, in HeLa cells and human primary fibroblast, 
with better efficiency than the gold standard employed for 




We have recently implemented the similar hydrazone and 
oxyme bond formation strategy for the modulation of the 
hydrophobic properties of penetrating peptides.
30,31
 The 
application of this approach to linear peptides allowed the 
straightforward modulation of the peptide hydrophobicity 
and, as a consequence, the peptide membrane translocation 
properties.
31
 Structural studies showed that the introduction 
of hydrophobic tails into the backbone of pro-helical linear 
peptides increased both helicity and amphiphilicity. These 
amphiphilic peptides showed self-adaptive capabilities 
depending on the external conditions such as in the transition 
from water to the lipid bilayer. Three hydrazone-modulated 
peptides from a simple screening showed an excellent level of 
transfection of plasmid DNA in human HeLa cells.
30
 
Cyclic peptides containing multiple aldehyde copies have been 
synthesized as scaffolds for the conjugation with hydrazides 
bearing guanidinium cations (Fig. 2C).
32,33
 The resulting acyl-
hydrazone cationic clusters were confirmed to dynamically 




Disulfide is another dynamic chemical bond that has been 
employed to study and improve cellular delivery (Fig. 2D).
26,34-40
 
In a very elegant approach, the group of Langel measured 
cytoplasm internalization kinetics by employing a disulfide 
linkage between a peptide cargo, labelled with a fluorophore, 
and a penetrating peptide carrier, bearing the corresponding 
fluorescent quencher (Fig. 2D).
35
 In this smart molecular probe, 
fluorescence emission could only be detected after glutathione 
digestion at the cytoplasm. This assay allowed the simple 
quantification of the real cytosolic delivery kinetics of a 
selection of well-known sequences of penetrating peptides. 
 
Fig. 2. Dynamic Bonds in Cell Delivery. A) Hydrazone linkage between a cationic guanidinium and cholestenone for DNA delivery. B) Differential sensing translated to 
delivery. Hydrazone Dendrons for the delivery of siRNA and oxime peptides for plasmid delivery. C) Cyclic peptide clusters for dynamic DNA complexation and 
release. D) Disulfide bond between a fluorophore and a quencher was applied to quantify gluthathione -mediated cytosol delivery kinetics. 
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2.3. Dynamic polymers for delivery applications. As initially 
proposed by Gait
37
 and confirmed by Matile,
38-41
 the presence 
of exo-facial thiols, offers a great opportunity to exploit 
dynamic covalent chemistry, at the cell membrane, to enhance 
intracellular uptake (Fig. 3A). The presence of accessible 
cysteine residues in membrane proteins triggers thiol-disulfide 
exchange with disulfide containing molecules that approach 
the outer leaflet of the cell membrane (Fig. 3A). Following 
disulfide attachment, the exogenous molecule can be 
internalized by different mechanisms (i.e. direct translocation, 
micellar pores, receptor mediated endocytosis, etc.). After 
membrane translocation, the action of the glutathione 
releases the compound from the membrane leading to the 
cytosol (Fig. 3A).
37
 After internalization, the reductive 
environment of the cytoplasm catalyses the digestion of the 




Intriguingly, the depolymerisation kinetics affected the 
internalization mechanism. Lengthy polydisulfides, which 
spend longer times of disulfide dynamic exchange at the 
membrane level, undergo endocytic uptake. Shorter 




Hydrazone bond formation has also been explored for the 
controlled delivery of therapeutic molecules.
42
 In a simple but 
very interesting design, Kataoka combined the polyethylene 
glycol (PEG) and the hydrazide functionalities in a block 
copolymer for intracellular delivery and controlled release (Fig. 
3B). Hydrazone formation with a hydrophobic drug (e.g. 
doxorubicin) afforded the corresponding amphiphilic polymer. 
The amphiphilic properties of the resulting hydrazone hybrid 
triggered its self-assembly into polymeric micelles of 
nanometric dimensions, which were applied in the slow 
release of the drug in malignant cells.
42
 Interesting grafted co-
 
Fig. 3. Dynamic Bonds in Cell Delivery. A) Polydisulfides for dynamic covalent cell delivery. Exofacial cell membrane thiols trap t he polydisulfide. The polymer is 
internalized by different mechanisms (i.e. micellar pores). The cytosolic glutathione releases the polymer in the cytosol. B) Polyethylene glycol hydrazone conjugates 
with hydrophobic cargo triggers micellar self assembly and enhanced delivery. C) Hydrazone grafted comb-like copolymers for gene delivery. D) Polyhydrazides can 
be in situ functionalized (i.e. in aqueous conditions and without further purification) with cationic and hydrophobic aldehydes. The res ulting amphiphilic polymers 
allow high-throughput screening of polymers for siRNA delivery in human HeLa cells.  
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polymers have also been synthesized in where the hydrazone 
bond was applied to graft, into the polymer backbone, the 
typical cationic and hydrophobic character from membrane 
penetrating molecules (Fig 3C).
43
 These comb-like polymers 
showed excellent levels of cellular transfection of anti-GAPDH 
siRNA in the presence of serum.
43
 
In collaboration with the group of Dr. Fernández-Trillo we have 
recently introduced the concept of “in situ” hydrazone 
functionalized polymers for intracellular delivery (Fig. 3D).
44
 In 
this novel approach, poly-hydrazides are simultaneously 
functionalized with cationic and hydrophobic aldehydes under 
physiological compatible conditions (e.g. DMSO/H2O) (Fig. 
3D).
44
 The resulting hydrazone-activated amphiphilic polymers 
were combined with the functional nucleotide cargo without 
any isolation or purification steps. These amphiphilic dynamic 
polymers turn out to be excellent transfection agents of siRNA 
in human HeLa cells. This modular methodology allows for the 
high-throughput screening of biologically relevant polymers 
over a consistent range of polymer length.
44
 In the future, the 
variation of the structure and the molar ratio of the two 
(cationic and hydrophobic) aldehyde pendants, could be a 
potential excellent alternative for the straightforward 
preparation of customized polymeric transporters for different 
cargos (i.e. siRNA versus plasmid DNA). 
2.4. Supramolecular host/guest delivery systems. Host/guest 
supramolecular entities have also inspired intriguing functional 
delivery systems. The cationic polymers containing cyclodextrin 
spacers, developed by Mark Davis, have shown great potential for 
siRNA therapeutic delivery (Fig. 4A). In these formulations, the 
cyclodextrin acts as biocompatible host for the inclusion of 
adamantane guests that are loaded together with stabilizers (e.g. 
PEG) and targeting motifs (e.g. transferrin) (Fig. 4A).
45-47
 The 
resulting hybrid polymers condensate siRNA to form stable 
nanoparticles that exhibit great delivery efficiency and that have 
been successfully assayed in clinical trials.
47
 
Cyclodextrins have also been employed as molecular templates for 
the controlled disposition of cationic charges and hydrophobic tails 
in a rigid molecular scaffold (Fig. 4B).
48,49
 In this approach, an 
efficient acylation method was used to functionalize the secondary 
hydroxy rims of the cyclodextrins. After alkylation, it was possible to 
further modify the hydrophilic surface of the primary rim by “click 
reactions” to incorporate cationic moieties and condensate and 
deliver functional DNA (Fig. 4B).
48
 This methodology was also used 
for macrophages targeting by decorating the cyclodextrins with 
mannosyl residues.
49
 Calix[n]arenes are also widely studied 




Fig. 4. Host/guest supramolecular complexes for delivery applications. A) In cationic cyclodextrin containing polymers, the adamant ane guests tailor PEG 
(protection) and Dextran (targeting) functionalities for improved siRNA delivery. B) Cyclodextrins  as templates for cationic and hydrophobic segregation for gene 
targeted delivery. C) Calixarenes templates for the circular clustering of cationic arginine and hydrophobic substituents. D)  Pillararenes and Fullerene templates for 
the globular arrangement of multiple cations for DNA interaction and biological applications (In the scheme Y represents the cationic moiety ). 
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Calix[4]arenes templates have been recently employed for the 
circular clustering of four arginines and the condensation and 
delivery of DNA in different cell lines (Fig. 4C).
51
 This study depicted, 
once again, that the topological disposition of the cationic arginine 
residues has important implications in the uptake and in the release 
of penetrating supramolecules, a situation also observed in recent 
studies with miniature proteins and penetrating peptides.
52-54
 The 
Nierengarten group has applied the similar methodology of cationic 
clustering for biological applications with supramolecular templates 
such as pillar[5]arenes
55
 and fullerenes (Fig. 4D,E).
56
 The efficient 
“click reactions” employed for the preparation of fullerenes, 
allowed the incorporation of dendrons, also used with pillaarenes, 
with two, four and eight ammonium groups per clickable group. The 
3D distribution of 96 amine residues for the third generation 
dendron over a globular template (Fig. 4E) provided a 
macromolecule that was efficiently employed for DNA 





3. Peptide Nanotubes 
3.1. Self-assembled peptide nanotubes (SCPNs), structural 
features. The particular architecture of cyclic peptide nanotubes 
allows the precise control over the nanotube diameter and the 
external properties by changing the number and the side chain of 
the amino acid monomers.
57,58
 These hollow linear 
supramolecular polymers are formed by the stacking of cyclic 
peptide (CP) rings composed of an even number of amino 
acids of a specific chirality, mainly the alternation of residues 
with opposite chirality. These features allow the CP to adopt a 
well-defined planar conformation that orient the amide 
backbone groups in a perpendicular disposition to the plane of 
the macrocycle. Therefore, an extended β-sheet-like 
hydrogen-bond network between each pair of cyclic peptide 
subunits can be established, resulting in the successive 
stacking of cyclic peptides on top of each other. The number of 
amino acids that form the cycle (generally from 6 to 12) 
determine the diameter of the SCPN (Fig. 5A). Importantly, all 
the amino acid side chains are displayed radially from the 
nanotube longitudinal axis. This arrangement allows a precise 
 
Fig. 5. Cyclic peptide nanotubes. A) Common cyclic peptide structure and nanotube formation through cyclic compound stacking. B) -cyclic peptide structures. C) 
Model of ion channel made by SCPN. D) Strategies for the formation of peptide/polymer nanotubular hybrids. E) Structure of Ja nus nanotubes made from a cyclic 
peptide bearing two orthogonal reactive ends and two polymers with different properties. F) Cyclic peptide containing a 3-amino-2-methylbenzoic acid that modifies 
the internal cavity of nanotubes used in gas transport films. 
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control over the external tubular decoration and potential reactive 
groups that would be displayed along the nanotube surface. Initial 
cyclic sequences of α-amino acids,
59







even the combination of two different types of amino acids (i.e. α, 
γ-CPs) (Fig. 5B).
63 
The self-assembling process of peptide nanotubes can be 
externally triggered by several approaches, generally by tuning 
the media conditions (i.e. pH modification).
59
 For example, the 
octapeptide c-[(Gln-D-Xxx-)4], in where Xxx can be Leu, Phe, Val 
or Ala, were soluble in acidic conditions and the assembly 
process was prompted by the slow increase of the pH.
64
 Under 
acidic conditions (TFA), the amide groups (peptide backbone 
and Gln side chains) are protonated, which increases peptide 
solubility and reduces aggregation as a consequence of the 
repulsive interactions of the protonated rings. These particular 
features made peptide nanotubes optimal candidates for the 
preparation of membrane partitioned functional systems such 
as ion channels (Fig. 5C).
65
 Our group has been continuously 
active in this field (vide infra).
65,66





 contributions, from 
different research groups, keep on demonstrating the 
potential of the cyclic peptide ring for the preparation of ion 
channels. Of particular interest is the application of these 
peptide channels for the transmembrane transport of 
anticancer drugs.
67
 Other helical self-assembled linear 




Recent advances in electron microscopy techniques, combined 
with novel nanomechanical analysis allowed the insightful 
characterization of the mechanical properties and the 
aggregation propensity of the Leu substituted peptide.
70
 This 
study revealed that the assembly of this CP, followed by a 
hierarchical bundling pattern, resulted in the formation of 
nanotube fibers. This bundling process gave rise to longer 
(several tens of μm) and thick (up to 1 μm) nanotubular 
bundles. The rigidity and the stretching resistance of these 
higher-order aggregates were determined to be among the 
best for protein nanofibers (i.e. collagen). Remarkably, these 
peptide bundles showed properties (i.e stiffness, rigidity) 
similar to the bone tissue with only a half of its density. 
3.2. SCPNs/polymer functional hybrids. The modification of 
the properties of peptide nanotubes with different polymeric 
coatings has attracted a big deal of attention in the recent 
years (Fig. 5D). SCPNs are among the best platforms for the 
selective disposition of certain functional groups towards a 
particular aligned region of the space.
57
 On the other hand, 
polymer science is experiencing a rapid growth in terms of new 
reactions, architectures and bio-conjugation.
4,71-73
 Therefore, 
the self-assembly properties of cyclic peptides can be applied 
to control the spatial orientation of polymers, which can be 
covalently or non-covalently attached to the tubular ensemble. 
Along these lines, following the original work by M. Biesalski,
74
 
Perrier’s group has developed several SCPN-polymer 
conjugates that allow the control of the nanotube formation 





 Different “clickable” polyacrylic acid derivatives 
or poly(2-ethyl-2-oxazoline)s (pEtOx) were attached as lateral 
chains of the peptide nanotube. The temperature sensitivity of 
similar poly(N-isopropylacrylamide)/SCPN hybrids has also 
been exploited to prepare ion channels whose trans-
membrane transport activity can be externally controlled. The 
polymer/peptide hybrids, inactive at room temperature, can 
self-assemble and insert into lipid bilayers upon heating. These 
thermally induced channels showed proton transport ability in 
dye-entrapped liposomes (LUVs).
77
 The radial disposition of 
two orthogonal reactive side chains in the cyclic peptides, 
allowed the preparation of Janus-like peptide/polymer 
nanotubes that could self assemble in the lipid bilayer forming 
membrane macro-pores (Fig. 5E).
78
 At this respect a new 
clickable isocyanate/primary amine conjugation has been 
developed by Perrier group and used in the formation of new 
SCPN hybrids that provide a new tool for increasing the 
diversity and properties of SCPN (Fig. 5E).
79
 
A SCPN/block copolymer hybrid has been developed, by Xu 
and co-workers, for the preparation of porous thin films of 
subnanometer dimensions.
80
 The conjugated polymer guides 
the nanotube growth in a confined geometry, affording porous 
membranes that contained high-density arrays of channels. 
This film allowed the transport of small molecular gases (i.e. 
CO2) or proton exchange through the interior of the nanotube 
pore.
80
 This strategy is a proof of concept for the generation of 
porous thin films whose channels can be modulated by the 
dimensions and the properties of the cyclic peptide (CP) used 
in the process. 
CPs attached to four norbornenes, through an ester linkage, 
allowed the preparation of robust polymers with lumens 
functionalized with carboxylate groups.
81
 The self-assembling 
of the cyclic peptide was used to template the ring opening 
cross-metathesis polymerization process between norbonenes 
CPs and a diamine linker that contains two norbonene 
moieties. The hydrolysis of ester bond of the resulting polymer 
liberated the CP templates leaving the free carboxylic acid and 
provided the macropores (around 100 nm) with carboxylate 
lumens.  
The use of SCPNs composites can also be used to reinforce the 
mechanical properties of polymeric systems (e.g. Lactic acid 
fibers).
82
 The composite fibers that incorporate about 8% of 
bundles of SCPNs derived from c-[(Gln-D-Leu-)4], turn out to be 
5 times stiffer than the same polymer fibers by itself. This 
design allowed the control of the fiber dimensions depending 
on the processing conditions.
82
 
3.3. Peptide nanotubes, internal cavity modulation. Several 
approaches using non-natural amino acids have been 
developed to modulate the properties of nanotube’s internal 
pore. Initial examples consisted on engineering cyclic peptides 





 -amino acids. The -amino acid contained a 
triazol ring for cavity functionalization. Unfortunately, the 
hydrophobic CH of the triazol was not project towards the  
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inner cavity. Instead, the heterocycle remained parallel to 
nanotube longitudinal axis.
62
 The approach, developed in our 
group, involving -amino acids employed 3-
aminocyclohexanecarboxylic acids to ensure the flat 
conformation of the peptide ring and to project the -carbon 
into the nanotube lumen.
62
 
The incorporation of 3-aminobenzoic acid in D,L--CPs 
constitutes an alternative for nanotube lumen 
functionalization.
83
 The presence of a methyl substituent in the 
aromatic ring (C2) gives a partial hydrophobic character to the 
nanotube interior without compromising the self-assembling 
properties (Fig. 5F). We have recently developed the first 
example in which a functional group was directed towards the 
ensemble cavity was based on non-aromatic -amino acids 
with a hydroxyl group in the -carbon (Fig. 6A).
84
 The 
octapeptide that contained two N-methylated-amino acids, 
requires the addition of a protic and polar solvent (e.g. MeOH, 
H2O) to interact with the inner hydroxyl groups and properly 
assemble into the corresponding dimer.
66
  
This hydroxy group can be chemoselectively modified to tune 
the cavity properties. Therefore, the incorporation of a 
pycolinic acid onto one of the hydroxyl groups transforms the 
properties of the resulting ensemble. The new peptide dimer 
generates a hollow structure that can entrap silver ions (Ag
+
) 
or dicarboxilic acids (Fig. 6B).
66
 Interestingly, a similar peptide, 
but without the N-methyl group in the hydroxylated -amino 
acid, folds in a “v-shaped” conformation. This folded peptide 
assembles in the presence of anions to form hexameric 
pseudo-spherical shaped structures (Fig. 6C).
85
 This recognition 
of anions, which induced peptide assembly, was used to 
transport chloride in an antiporter fashion (exchange of 
chloride ion from the outside for nitrate) across a lipid bilayer. 
This was demonstrated by fluorescence experiments involving 
the quenching of an anion dependent fluorophore. This kind of 
supramolecular anion receptors could have important 
applications in organocatalysis, industrial anion separation, ion 
sensing or treatment of diseases, such as cystic fibrosis.
86,87
 
The conjugation of SCPN with different nanostructures has 
been developed to expand the potential applications of the 
“naked” nanotubes. For example, the incorporation of 
electroactive moieties was studied to develop electronic 
nanocomponents.
88
 The covalent incorporation of 
naphthalenetetracarboxylic diimide moieties into the cyclic 
peptide ring provided the first example of an electron 
activated peptide nanotube.
88
 The resulting electronic 
delocalized nanotube was hundreds of nanometer in length. In 
an analogous approach, a fullerene moiety was also attached 
to a nanotube forming cyclic peptide (Fig. 6D).
89
 In this case, 
perhaps as a consequence of the bulkiness of the C60 moiety, 
the deposition of the SCPN on surfaces was accomplished by 
alternating the fullerene moieties at both sides of a single 
nanotube. The parallel disposition of the two molecular wires 
obtained might found applications in electronic nanocircuits. 
Small vertically oriented SCPNs were grown over gold by the 
layer-by-layer deposition method. This strategy was 
implemented to study the charge transfer processes along 
 
Figure 6. Peptide nanotubes internal functionalization and functional supramolecular hybrids. A) -amino acids with hydroxyls for the introduction of pyridyl for 
internal functionalization. B) The pyridine allows metal (silver) coordination. C) Without N-methylation the peptide folds in a v-shaped conformation that self-
assembles into hexameric structures and coordinates and transport anion across the lipid bilayer. D) E) and F) Hierarchical surface deposition of peptide/fu llerene 
(D), peptide/carbon nanotubes (E) and peptide/subnanometric metal clusters (F) hybrid nanotubes. G) Venturi -like peptide nanotubes. 
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nanotubular supramolecular motifs.
90
 This special 
arrangement allowed the study of the dependence of the 
current as a function of nanotube length. The results showed 
that, in this architecture, the efficient charge transfer was 
achieved at the low voltage region. However, a transfer to 




3.4. Peptide nanotubes functional supramolecular hybrids. 
The use of non-covalent interactions to prepare nanotubular 
functional supramolecular hybrids has been recently 
approached (Fig. 6E and 6F).
91,92
 Our group has developed a 
cyclic peptide alternating α and γ aminoacids that was 
equipped with a pyrene on a lysine residue. This CP can self-
assemble into nanotubes both in aqueous solution and over 
mica surface.
91
 This pyrene “paddle” was used to interact and 
to assist in the aqueous dispersion of carbon nanotubes 
(CNTs).
91
 The resulting peptide/carbon tubular twins combined 
the properties of both components, the biocompatibility and 
solubility of SCPNs and the strength and electronic properties 
of the carbon nanotube counterpart. Therefore, the aqueous 
dispersions of cyclic peptides and carbon nanotubes were used 
for the controlled deposition (for TEM and AFM analysis) of 
the corresponding hybrid tubes (Fig. 6E). The supramolecular 
nature of the approach maintained the properties of the 
carbon nanotubes unaltered and provided insights about new 
strategies for CNT manipulation and controlled deposition. 
Electron and AMF micrographs of the deposited nanotubes 




Our group has recently implemented these peptide nanotubes 
decorated with pyrene paddles for the alignment of 
subnanometric silver-clusters (Ag3) (Fig. 6F).
92
 This pioneering 
work exhibited one of the first examples in which a long 
(several μm) 1D array of these subnanometric metal clusters 
were observed. This was achieved using previously synthesized 
atomic metal cluster lacking any ligand or stabilizer. These 
results depicted the importance that non-covalent interactions 
(i.e. van der Waals forces, π-stacking, hydrophobic effects, 




The potential to decorate peptide nanotubes with different 
components triggers intracellular delivery opportunities.
93-95
 
SCPNs bundles loaded with doxorubicin and further 
biocompatibilized by PEGylation have been tested for drug 
delivery.
94
 The resulting complex showed a good level of 
cytotoxicity in human breast cancer cells. The authors 
proposed that this was probably due to an increased uptake 
and intracelular distribution of the doxorubicin payload.
94
 
Alternatively, a cationic (lysine) cyclic peptide, with a lysine 
residue modified with an artificial guanidiniocarbonyl-pyrrole 
moiety, allowed the formation of cationic nanofibers that 
complexed and delivered DNA.
95
 A hydrophobic 
diketopiperazine made by D-Trp and Tyr was used in oral gene 
delivery.
93
 The fibers derived from this CP were able to protect 
the DNA attached to the fibers surface from the DNase I and 
acidic digestion. The plasmid permeation took place through 
an energy-dependent process. The results indicated that these 
materials can act as nanovectors for the oral delivery to the 
duodenum, stomach liver and kidney.
93
 Previously mentioned 
SCPN/polymer hybrids were also studied in drug conjugation.
96
 
In this study, the ruthenium-based anticancer drug (RAPTA) 
was conjugated to the copolymer that formed the nanotubular 
shell. The resulting structures exhibited a promising activity 
against cisplatin-resistant ovarian cancer cell lines. 
Nanotube-forming CPs have already found several applications 
as ion channels, antimicrobial or antiviral agents.
8,65
 The 
similarity of the chemical and biochemical properties of 
amyloids with peptide nanotubes facilitate their cross-
interaction. Recent studies have shown their ability to 
modulate the aggregation and toxicity of amyloid beta (Aβ).
97
 
Hexameric D,L-CPs interact with small oligomeric form of Aβ 
(1−3 mer), apparently through the stabilization of the parallel 
β-sheet conformation. As a result, the CP shifted the amyloid 
aggregation to yield less toxic structures that provide anti-
amyloidogenic properties.
97
 Recently, or group has achieved 
the click conjugation of two different dimer-forming cyclic 
peptides with different diameters (Fig. 6G).
98
 To form the 
covalent heterodimer, one cyclic tetrapeptide was 
functionalized with a 3-propyl azide at the peptide skeleton 
while the cyclic octapeptide was modified with an propargyl 
moiety.
98
 The click reaction afforded the final heterodimer that 
self-assembles, under controlled conditions, to yield different 
architectures (Fig. 6G). The difference between the association 
constant of two peptides, allowed the preparation of short 
nanotubes with precise length control (Fig. 6G). Changing 
parameters such as sample concentration or solvent 
properties modulated peptide length. In this way, nanotubes 





The mature field of supramolecular chemistry increases each 
day its potential applications in the development of functional 
devices. This is not surprising as functional properties emerge, 
in many occasions and especially in biology, from weak and 
non-covalent interactions between macromolecular 
counterparts. In this regard, it is important to remark that 
synthetic and organic chemistry will always be needed to 
create the new building blocks required for supramolecular 
functional devices. This feature article highlighted a few 
contributions from ours and other research groups to this 
emerging an exciting field. We have just focused in 
supramolecular delivery with special attention in dynamic 
bonded systems. In the first section of this paper we have 
commented examples related with differential sensing systems 
in lipid bilayers, dynamic bonds and cationic clustering for 
gene delivery and host/guest complexes with biological 
applications. In the second part of the article we reviewed 
different strategies for functional peptide nanotubes in the 
fabrication of porous films, molecular capsules, carbon 
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nanocomposites, ion channels and supramolecular templates 
among others. The insights extracted from this review, point 
out the strengths and improvements already accomplished as 
well as the key problems that still need to be overcome. As the 
synthetic methods improve and the field of supramolecular 
chemistry evolves, it seems essential, for self-assembled 
supramolecular architectures, to achieve the precise control 
over the spatial distribution and presentation of the functional 
molecular moieties. This paper subtly outlined some other 
future potential directions such as implementation of dynamic 
bonds in smart stimuli responsive delivery vehicles or the 
supramolecular recognition for protein delivery and cell 
targeting. There is still a lot to be done in this exciting field and 
we very much hope that these small lessons can help us to 
learn how the nano and the bio world behaves and how to 
control it for our own benefit. 
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